Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The Restoring Insulin Secretion (RISE) Adult Medication Study compared pharmacological approaches targeted to improve β-cell function in individuals with impaired glucose tolerance (IGT) or treatment-naive type 2 diabetes of <12 months duration. RESEARCH DESIGN AND METHODS: A total of 267 adults with IGT (n = 197, 74%) or recently diagnosed type 2 diabetes (n = 70, 26%) were studied. Participants were randomized to receive 12 months of metformin alone, 3 months of insulin glargine with a target fasting glucose <5 mmol/L followed by 9 months of metformin, 12 months of liraglutide combined with metformin, or 12 months of placebo. β-Cell function was assessed using hyperglycemic clamps at baseline, 12 months (on treatment), and 15 months (3 months off treatment). The primary outcome was β-cell function at 15 months compared with baseline. RESULTS: All three active treatments produced on-treatment reductions in weight and improvements in HbA1c compared with placebo; the greatest reductions were seen in the liraglutide plus metformin group. At 12 months, glucose-stimulated C-peptide responses improved in the three active treatment groups and were greatest in the liraglutide plus metformin group, but the arginine-stimulated incremental C-peptide response was reduced in the liraglutide plus metformin group. Despite on-treatment benefits, 3 months after treatment withdrawal there were no sustained improvements in β-cell function in any treatment group. CONCLUSIONS: In adults with IGT or recently diagnosed type 2 diabetes, interventions that improved β-cell function during active treatment failed to produce persistent benefits after treatment withdrawal. These observations suggest that continued intervention may be required to alter the progressive β-cell dysfunction in IGT or early type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Affected young people have a more rapid deterioration in blood glucose levels, an attenuated response to diabetes medication, and more rapid development of diabetes complications (269 -273).”
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
An Efficient Method of Estimating Seemingly Unrelated Regressions and Tests for Aggregation Bias
Zellner, A. (1962) · Journal of the American Statistical Association · doi:10.1080/01621459.1962.10480664 · Cited by 8,401
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“Similarly, in established diabetes, progressive loss of glycemic control arises from ongoing deterioration of b-cell function (2).”
BackgroundSelf-citationWeyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
The Finnish Diabetes Prevention Study (DPS)
Lindström, J., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Eriksson, J., Uusitupa, M., Tuomilehto, J., & for the Finnish Diabetes Prevention Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3230 · Cited by 1,848
Basal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636
The Generalization of Student's Ratio
Hotelling, H. (1931) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177732979 · Cited by 1,492
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
Self-citation(2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00291-0 · Cited by 1,029
le Roux, C. W., Astrup, A., Fujioka, K., Greenway, F., Lau, D. C. W., Van Gaal, L., Ortiz, R. V., Wilding, J. P. H., Skjøth, T. V., Manning, L. S., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30069-7 · Cited by 850
Weng, J., Li, Y., Xu, W., Shi, L., Zhang, Q., Zhu, D., Hu, Y., Zhou, Z., Yan, X., Tian, H., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60762-x · Cited by 780
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
DeFronzo, R. A., Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Henry, R. R., Hodis, H. N., Kitabchi, A. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010949 · Cited by 766 · cited 2×
“with thiazolidinediones (9,10,20,21) have been show to affect the natural history of progressive b-cell dysfunction.”
BackgroundSelf-citationBonner, C., Kerr-Conte, J., Gmyr, V., Queniat, G., Moerman, E., Thévenet, J., Beaucamps, C., Delalleau, N., Popescu, I., Malaisse, W. J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3828 · Cited by 670 · cited 1×
“transporter 2 inhibitors, have not been evaluated for diabetes prevention, but the newly recognized actions on a-cells to drive glucagon production (39) do not augur well for a beneficial effect on b-cells.”
BackgroundPrevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention Program
The Diabetes Prevention Program Research Group* (2005) · Diabetes · doi:10.2337/diabetes.54.4.1150 · Cited by 474
Taylor, R., Al-Mrabeh, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Aribisala, B. S., Hollingsworth, K. G., Mathers, J. C., Sattar, N., & Lean, M. E. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.003 · Cited by 450
The Diabetes Prevention Program Research Group (2005) · Diabetes · doi:10.2337/diabetes.54.8.2404 · Cited by 446
Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Kawakubo, M., & Buchanan, T. A. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-1066 · Cited by 402
Self-citationBunck, M. C., Diamant, M., Cornér, A., Eliasson, B., Malloy, J. L., Shaginian, R. M., Deng, W., Kendall, D. M., Taskinen, M.-R., Smith, U., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1797 · Cited by 388
Seemingly unrelated regression equations models : estimation and inference
Srivastava, V. K., & Giles, D. E. A. (1987) · Cited by 319
systemfit: A Package for Estimating Systems of Simultaneous Equations in R
Henningsen, A., & Hamann, J. D. (2007) · Journal of Statistical Software · doi:10.18637/jss.v023.i04 · Cited by 277
Kahn, S. E., Lachin, J. M., Zinman, B., Haffner, S. M., Aftring, R. P., Paul, G., Kravitz, B. G., Herman, W. H., Viberti, G., Holman, R. R., et al. (2011) · Diabetes · doi:10.2337/db10-1392 · Cited by 249
Self-citationBunck, M. C., Cornér, A., Eliasson, B., Heine, R. J., Shaginian, R. M., Taskinen, M.-R., Smith, U., Yki-Järvinen, H., & Diamant, M. (2011) · Diabetes Care · doi:10.2337/dc11-0291 · Cited by 240
The Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.4.977 · Cited by 218
Lindström, J., Peltonen, M., Eriksson, J. G., Aunola, S., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Uusitupa, M., Tuomilehto, J., & for the Finnish Diabetes Prevention Study (DPS) Group (2008) · Diabetes Care · doi:10.2337/dc07-2162 · Cited by 168
The RISE Consortium, Ehrmann, D. A., Temple, K. A., Rue, A., Barengolts, E., Mokhlesi, B., Van Cauter, E., Sam, S., Miller, M. A., Kahn, S. E., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0244 · Cited by 162
Self-citationRetnakaran, R., Kramer, C. K., Choi, H., Swaminathan, B., & Zinman, B. (2014) · Diabetes Care · doi:10.2337/dc14-0893 · Cited by 136
3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s003 · Cited by 124
Prevention of Diabetes With Pioglitazone in ACT NOW
DeFronzo, R. A., Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Gastaldelli, A., Henry, R. R., Kitabchi, A. E., et al. (2013) · Diabetes · doi:10.2337/db13-0265 · Cited by 109
Self-citationLachin, J. M., Christophi, C. A., Edelstein, S. L., Ehrmann, D. A., Hamman, R. F., Kahn, S. E., Knowler, W. C., Nathan, D. M., & on behalf of the DPP Research Group (2007) · Diabetes · doi:10.2337/db06-0918 · Cited by 107
Self-citationHu, Y., Li, L., Xu, Y., Yu, T., Tong, G., Huang, H., Bi, Y., Weng, J., & Zhu, D. (2011) · Diabetes Care · doi:10.2337/dc10-2105 · Cited by 102
The RISE Consortium (2014) · Diabetes Care · doi:10.2337/dc13-1879 · Cited by 100
Self-citationHannon, T. S., Kahn, S. E., Utzschneider, K. M., Buchanan, T. A., Nadeau, K. J., Zeitler, P. S., Ehrmann, D. A., Arslanian, S. A., Caprio, S., Edelstein, S. L., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13005 · Cited by 87
Self-citationLiraglutide Compromises Pancreatic β Cell Function in a Humanized Mouse Model
Abdulreda, M. H., Rodriguez‐Diaz, R., Caicedo, A., & Berggren, P. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.009 · Cited by 83
Protective Action of Liraglutide in Beta Cells Under Lipotoxic Stress Via PI3K/Akt/FoxO1 Pathway
Shao, S., Nie, M., Chen, C., Chen, X., Zhang, M., Yuan, G., Yu, X., & Yang, Y. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24763 · Cited by 55
Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial
McInnes, N., Smith, A., Otto, R., Vandermey, J., Punthakee, Z., Sherifali, D., Balasubramanian, K., Hall, S., & Gerstein, H. C. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3373 · Cited by 53
Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Henry, R. R., Kitabchi, A. E., Mudaliar, S., Ratner, R. E., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4202 · Cited by 48
Self-citationXiang, A. H., Trigo, E., Martinez, M., Katkhouda, N., Beale, E., Wang, X., Wu, J., Chow, T., Montgomery, C., Nayak, K. S., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1662 · Cited by 37 · cited 1×
“early type 2 diabetes is not superior to ongoing metformin alone (40).”
BackgroundSelf-citationRetnakaran, R., Choi, H., Ye, C., Kramer, C. K., & Zinman, B. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13236 · Cited by 21
Luo, X., Pan, L., Nie, A., Wang, Q., Gu, Y., Li, F., Zhang, H., Li, W., & Li, X. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12061 · Cited by 14
Patel, Y. R., Kirkman, M. S., Considine, R. V., Hannon, T. S., & Mather, K. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2056 · Cited by 6
Self-citation
Cited by
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05787-2 · Cited by 1,048
Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Eizirik, D. L., Pasquali, L., & Cnop, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0355-7 · Cited by 854
Long-term complications in youth-onset type 2 diabetes
TODAY Study Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100165 · Cited by 546
Diagnosis and Management of Prediabetes: A Review
Echouffo-Tcheugui, J. B., Perreault, L., Ji, L., & Dagogo-Jack, S. (2023) · JAMA · doi:10.1001/jama.2023.4063 · Cited by 473
Metadata
- Authors
- The RISE Consortium, Ehrmann, D. A., Temple, K. A., Rue, A., Barengolts, E., Mokhlesi, B., Van Cauter, E., Sam, S., Miller, M. A., Kahn, S. E., Atkinson, K. M., Palmer, J. P., Utzschneider, K. M., Gebremedhin, T., Kernan-Schloss, A., Kozedub, A., Montgomery, B. K., Morse, E. J., Mather, K. J., Garrett, T., Hannon, T. S., Lteif, A., Patel, A., Chisholm, R., Moore, K., Pirics, V., Pratt, L., Nadeau, K. J., Gross, S., Zeitler, P. S., Williams, J., Cree-Green, M., Garcia Reyes, Y., Vissat, K., Arslanian, S. A., Brown, K., Guerra, N., Porter, K., Caprio, S., Savoye, M., Pierpont, B., Buchanan, T. A., Xiang, A. H., Trigo, E., Beale, E., Chow, T., Hendee, F. N., Katkhouda, N., Nayak, K., Martinez, M., Montgomery, C., Wang, X., Wu, J., Edelstein, S. L., Lachin, J. M., Tjaden, A. H., Marcovina, S., Harting, J., Albers, J., Hill, D., Savage, P. J., & Leschek, E. W.
- ORCID
- Mokhlesi, Babak
- Kahn, Steven E.
- Atkinson, Karen M.
- Utzschneider, Kristina M.
- Mather, Kieren J.
- Hannon, Tamara S.
- Nadeau, Kristen J.
- Zeitler, Philip S.
- Arslanian, Silva A.
- Caprio, Sonia
- Buchanan, Thomas A.
- Xiang, Anny H.
- Beale, Elizabeth
- Chow, Ting
- Martinez, Mayra
- Wang, Xinhui
- Wu, Jun
- Edelstein, Sharon L.
- Lachin, John M.
- Tjaden, Ashley Hogan
- Marcovina, Santica
- Leschek, Ellen W.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-06-09
- Volume
- 42
- Issue
- 9
- Pages
- 1742-1751
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC6702605
- OpenAlex
- W4241784903
- Cited by
- 73
- References
- 40
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 5 · 2023: 11 · 2022: 16 · 2021: 18 · 2020: 9 · 2019: 3
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK-094406, U01DK-094430, U01DK-094431, U01DK-094438, U01DK-094467, P30DK-017047, P30DK-020595, P30DK-045735, P30DK-097512)
- National Center for Advancing Translational Sciences (UL1TR-000430, UL1TR-001082, UL1TR-001108, UL1TR-001855, UL1TR-001857, UL1TR-001858, UL1TR-001863)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- beta-cell function, impaired glucose tolerance, type 2 diabetes, metformin, insulin glargine, liraglutide, treatment withdrawal, hyperglycemic clamp, C-peptide response, insulin secretion
- MeSH terms
- Insulin Glargine, Liraglutide, Adult, Arginine, B-Lymphocytes, Blood Glucose, Body Weight, C-Peptide, Diabetes Mellitus, Type 2, Fasting, Female, Humans, Hypoglycemic Agents, Insulin Resistance, Male, Metformin, Middle Aged, Glucose Intolerance, Withholding Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.